United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
30.56%
2025 (actual)
ROA
1.44%
2025 (actual)
Gross Margin
53.3%
2025 (actual)
Net Margin
3.01%
2025 (actual)
Total Assets
$12,867.00M
2025 (actual)
Net Income
$187.00M
2025 (actual)
Valuation
$1,878.26M
2026 (forecast)
Stock Price
$7.15
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-45.7 pt
Company
Sector average
ROA
-2.5 pt
Company
Gross Margin
-17.1 pt
Company
Sector average
Net Margin
-5.2 pt
Company
Total Assets
+66.7%
Company
Sector average
Net Income
-212.7%
Company
Valuation
-86.9%
Company
Sector average (own scale)
Stock Price
-86.9%
Company
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Organon & Co.? It covers the balance sheet, income statement, cash flow and Equlion model projections.